---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-046203"
form_type: "8-K"
ticker: "RMTG"
cik: "0001760026"
company_name: "Regenerative Medical Technology Group Inc."
filed_at: "2025-05-21T23:59:59+00:00"
generated_at: "2026-05-20T22:39:56.889884+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# RMTG Q1 sales up 67% to $1.35M; achieves operating profit of $134K

## Summary
- Q1 2025 revenue $1.35M, a 67% increase over Q1 2024.
- Operating profit of $134,000 for the quarter; positive cash flow noted.
- New Turnkey membership revenue stream: clinics pay upfront fee and exclusive purchasing.
- RMTG plans one new member per quarter initially, accelerating next year.
- CEO expects continued revenue growth and sustained operating income; formal guidance forthcoming.

## SEC filing metadata
- accession: 0001213900-25-046203
- form_type: 8-K
- ticker: RMTG
- cik: 0001760026
- company_name: Regenerative Medical Technology Group Inc.
- filed_at: 2025-05-21T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1760026/000121390025046203/0001213900-25-046203-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1760026/000121390025046203/ea0242973-8k_regenerative.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-046203
- JSON: https://secwatch.observer/filing/0001213900-25-046203.json
- Plain text: https://secwatch.observer/filing/0001213900-25-046203.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.